Efeito Placebo Aplicado a Ambientes Clínicos e de Desempenho Físico Uma Revisão Narrativa

Introdução: Placebo é considerado uma substância ou um procedimento inerte que pode proporcionar um efeito positivo ou negativo dependendo da condição em que é aplicado. É bem documentado que o placebo promove resultados positivos em condições patológicas e em condições de desempenho físico. Objetivo: Sendo assim, objetivo desse estudo é revisar em duas sessões, trabalhos que tenham abordado: 1) o efeito placebo e nocebo aplicado à clínica no tratamento da doença de Parkinson, depressão e dor, e 2) o uso do placebo como recurso ergogênico no desempenho físico. Metodologia: Para tal, uma busca foi realizada na base de dados “Pubmed” e “Web of Science”. Resultados e discussão: Nesta revisão narrativa, discutimos como o efeito placebo atua em diversas condições como a dor, depressão, doença de Parkinson, e no desempenho físico, além disso, foram abordados possíveis mecanismos que possam atuar neste fenômeno. Conclusão: Podemos concluir que em condição clínica e de desempenho físico, o placebo compartilha regiões cerebrais semelhantes, que geram respostas positivas ao tratamento.

Referências

BEEDIE, Christopher. J. et al. Placebo effects of caffeine on cycling performance. Medicine and science in sports and exercise, v. 38, n. 12, p. 2159–2164, dez. 2006.

BEEDIE, Christopher J. Placebo effects in competitive sport: qualitative data. J Sports Sci Med, v. 6, n. 1, p. 21–28, Mar, 2007.

BEEDIE, Christopher. J.; COLEMAN, Damian A.; FOAD, Abigail J. Positive and negative placebo effects resulting from the deceptive administration of an ergogenic aid. Int J Sport Nutr Exerc Metab, v. 17, n. 3, p. 259–269, Jun, 2007.

BEEDIE, Christopher. J.; FOAD, Abigail J.; COLEMAN, Damian A. Identification of Placebo Responsive Participants in 40km Laboratory Cycling Performance. Journal of Sports Science & Medicine, v. 7, n. 1, p. 166–175,Mar, 2008.

BENEDETTI, Fabrizio et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of neuroscience : the official journal of the Society for Neuroscience, v. 23, n. 10, p. 4315–4323, maio 2003.

BENEDETTI, Fabrizio et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature neuroscience, v. 7, n. 6, p. 587–588, jun, 2004.

BENEDETTI, Fabrizio et al. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience, v. 147, n. 2, p. 260–271, jun, 2007.

BENEDETTI, Fabrizio. Placebo effects: from the neurobiological paradigm to translational implications. Neuron, v. 84, n. 3, p. 623–637, nov, 2014.

BENEDETTI, Fabrizio ; AMANZIO, Martina. Mechanisms of the placebo response. Pulmonary pharmacology & therapeutics, v. 26, n. 5, p. 520–523, out, 2013.

BRIETZKE, Cayque et al. Caffeine Effects on VO2MAX Test Outcomes Investigated by a Placebo Perceived-as-Caffeine Design. Nutrition and Health, dez, 2017.

CLARK, Virginia R. et al. Placebo effect of carbohydrate feedings during a 40-km cycling time trial. Med Sci Sports Exerc, v. 32, n. 9, p. 1642–1647, set, 2000.

COLLOCA, Luana.; BENEDETTI, Fabrizio. Placebos and painkillers: is mind as real as matter? Nature reviews. Neuroscience, v. 6, n. 7, p. 545–552, jul, 2005.

DE LA FUENTE-FERNANDEZ, Raúl et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science (New York, N.Y.), v. 293, n. 5532, p. 1164–1166, ago, 2001.

ELLINGSEN, Dan-Mikael et al. Placebo improves pleasure and pain through opposite modulation of sensory processing. Proceedings of the National Academy of Sciences of the United States of America, v. 110, n. 44, p. 17993–17998, out, 2013.

FOAD, Abigail J.; BEEDIE, Christopher. J.; COLEMAN, Damian A. Pharmacological and psychological effects of caffeine ingestion in 40-km cycling performance. Med Sci Sports Exerc, v. 40, n. 1, p. 158–165, jan, 2008.

FRISALDI, Elisa et al. The placebo effect on bradykinesia in Parkinson’s disease with and without prior drug conditioning. Movement disorders : official journal of the Movement Disorder Society, v. 32, n. 10, p. 1474–1478, out, 2017.

GREEN, Alexander L. et al. Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans. The Journal of physiology, v. 578, n. Pt 2, p. 605–612, jan, 2007.

KAUFMANN, Horacio et al. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology, v. 59, n. 10, p. 1657—1658, 2002.

KONG, Jian et al. Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Rev Neurosci, v. 18, n. 3–4, p. 173–190, ago, 2007.

LANOTTE, Michele et al. Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain, behavior, and immunity, v. 19, n. 6, p. 500–509, nov, 2005.

LEUCHTER, Andrew F. et al. Changes in brain function of depressed subjects during treatment with placebo. The American journal of psychiatry, v. 159, n. 1, p. 122–129, jan, 2002.

MAYBERG, Helen S. et al. The functional neuroanatomy of the placebo effect. The American journal of psychiatry, v. 159, n. 5, p. 728–737, maio, 2002.

MERCADO, Rodrigo et al. Expectation and the placebo effect in Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Movement disorders : official journal of the Movement Disorder Society, v. 21, n. 9, p. 1457–1461, set, 2006.

PETROVIC, Predrag et al. Placebo and opioid analgesia-- imaging a shared neuronal network. Science, v. 295, n. 5560, p. 1737–1740, mar, 2002.

PETROVIC, Predrag et al. Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network. Neuron, v. 46, n. 6, p. 957–969,jun, 2005.

POLLO, Antonella et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport, v. 13, n. 11, p. 1383–1386, ago, 2002.

POLLO, Antonella.; CARLINO, Elisa.; BENEDETTI, Fabrizio. The top-down influence of ergogenic placebos on muscle work and fatigue. The European journal of neuroscience, v. 28, n. 2, p. 379–388, jul. 2008.

PRICE, Donald D. et al. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain, v. 127, n. 1–2, p. 63–72, jan, 2007.

PRICE, Donald D.; FINNISS, Damien G..; BENEDETTI, Fabrizio. A comprehensive review of the placebo effect: recent advances and current thought. Annual review of psychology, v. 59, p. 565–590, jan, 2008.

SAUNDERS, Blair et al. Placebo in sports nutrition: a proof-of-principle study involving caffeine supplementation. Scand J Med Sci Sports, nov, 2016.

THORNTON, Judith M. et al. Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. The Journal of physiology, v. 539, n. Pt 2, p. 615–621, mar, 2002.

TROJIAN, Thomas H.; BEEDIE, Christopher J. Placebo effect and athletes. Curr Sports Med Rep, v. 7, n. 4, p. 214–217, jul, 2008.

WAGER, Tor D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science, v. 303, n. 5661, p. 1162–1167, fev, 2004.

WALSH, B. Timothy et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA, v. 287, n. 14, p. 1840–1847, abr, 2002.

Acessar